Sign in

ICMR calls for more studies on plan to use bugged mosquitoes

“ICMR has asked for more studies to be done in the laboratory to see how well it works before these bugged mosquitoes are released into the community,” a central government official aware of the matter said, requesting anonymity. “Community trials come at a later stage; first it has to be well established in the lab.”

Updated on: Jul 10, 2022, 03:04:39 IST
By , New Delhi
Share
Share via
  • facebook
  • twitter
  • linkedin
  • whatsapp
Copy link
  • copy link

It may take longer for the government’s ambitious project of controlling vector-borne diseases such as dengue and chikungunya through releasing bugged mosquitoes that prevent virus replication in endemic areas, as the Indian Council of Medical Research (ICMR) has sought more virus challenge studies to be done from one of its institutes to establish more effectively that the process would work, according to people familiar with the matter.

Indian Council of Medical Research (ICMR) has sought more virus challenge studies to be done from one of its institutes to establish more effectively that the process of releasing bugged mosquitoes would work. (AFP)
Indian Council of Medical Research (ICMR) has sought more virus challenge studies to be done from one of its institutes to establish more effectively that the process of releasing bugged mosquitoes would work. (AFP)

“ICMR has asked for more studies to be done in the laboratory to see how well it works before these bugged mosquitoes are released into the community,” a central government official aware of the matter said, requesting anonymity. “Community trials come at a later stage; first it has to be well established in the lab.”

Dengue is a huge public health concern in many parts of the world, including India, and vector-control measures aren’t much effective if they do not start well before the onset of rainy season.

ICMR’s Pondicherry-based Vector Control Research Centre (VCRC) is working on a research project where it developed two colonies of Aedes aegypti (the mosquito that hosts the dengue virus), infected with wMel and wAlbB Wolbachia strains called Ae. aegypti (Pud).

Evidence so far suggests the infected mosquitoes with the wolbachia strains are less susceptible than wild mosquitoes to dengue virus infection.

“The data available so far show that the strategy works but we are currently in the process of conducting more lab-based experiments to establish with more authority that the bug that is artificially lodged in a mosquito stops virus replication,” said Ashwani Kumar, director, ICMR-VCRC.

There was no question of releasing the bugged mosquitoes in the wild as it would require government approvals at the highest level, he added.

“No permissions have been granted as yet in this regard. This will be a long-drawn process as we will go back to the secretary of the department of health research with our trial results after a few months after the results are out,” said Kumar. “The secretary, who is also director general ICMR, will have to then constitute a high-level committee that will largely comprise external experts to review the trial data, and take a decision.”

Even if the permission is granted for community-based trials, it has to be done as a pilot project as the process would require releasing a batch every week for at least six months, he added.

In 2017, India inked a pact with Australia for technology transfer as the method has been successful in at least five countries, including Australia.

  • Rhythma Kaul
    ABOUT THE AUTHOR
    Rhythma Kaul

    Rhythma Kaul is the national health editor of the Hindustan Times. She has been reporting on public health, medicine, and medical research, with a particular focus on how government decisions and health system reforms shape people’s lives. Rhythma has over 25 years of journalistic experience. She joined Hindustan Times in 2008, and has since covered everything from pandemics and infectious diseases to cutting‑edge medical research and climate‑related health challenges. Her stories routinely track the work of the Ministry of Health and Family Welfare, department of pharmaceuticals, and key national health programmes, making complex medical science and policy accessible to a wide audience. One of her prominent news breaks has been the 2012 Baby Falak case: A two-year-old brutally battered baby girl was admitted to AIIMS-Delhi with severe head injuries, multiple fractures, human bite marks, and burns. The police investigation revealed this to be a case of multi-state human-trafficking racket. She was profiled by The Wall Street Journal for breaking this story. Rhythma holds a Master’s degree from Jawaharlal Nehru University, Delhi. Prior to Hindustan Times, she worked with the India Today Group. Rhythma can be contacted at rhythma.kaul@hindustantimes.com. Her X handle is @RamblingBrook.Read More